Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Asthma: Pathogenesis and Management

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genome-wide study identifies a locus associated with atopic dermatitis severity in a canine model.

The Journal of investigative dermatology·2026

Same author

Theories and mechanisms of environmental factors that cause allergies in dogs: veterinarian involvement in lifestyle choices to support long-term well-being.

American journal of veterinary research·2025

Same author

Environmental factors are responsible for the rise of atopic dermatitis in dogs: veterinarians should focus on modifiable influences.

Journal of the American Veterinary Medical Association·2025

Same author

Antibiotic resistance in equine dermatology: what should we do?

Journal of the American Veterinary Medical Association·2025

Same author

In vitro use of a low-level laser therapy device inhibits growth of Malassezia pachydermatis.

American journal of veterinary research·2025

Same author

Skin Barrier in Normal and Allergic Horses: What Do We Know?

Veterinary sciences·2025

Search research articles

Related Experiment Video

Updated: Jun 13, 2026

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

Published on: December 27, 2024

Canine atopic dermatitis: what's new?

Rosanna Marsella¹

¹University of Florida, USA.

Compendium (Yardley, PA)

|May 18, 2010

Summary

Canine atopic dermatitis (AD) management is evolving. A proactive approach focusing on improving skin barrier function in young dogs may reduce future allergic sensitization, shifting from reactive inflammation control.

Area of Science:

Veterinary Dermatology
Immunology
Canine Health

Background:

Canine atopic dermatitis (AD) is a common allergic skin disease.
Understanding of AD triggers, diagnosis, and management has advanced.
Skin barrier dysfunction is increasingly recognized in AD pathogenesis.

Purpose of the Study:

To review current understanding of canine atopic dermatitis (AD).
To discuss clinical features, allergy testing pitfalls, and recent research.
To propose a shift towards proactive management strategies for AD.

Main Methods:

Literature review of canine atopic dermatitis.
Analysis of clinical features and diagnostic challenges.
Evaluation of emerging research on skin barrier function.

More Related Videos

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

Related Experiment Videos

Last Updated: Jun 13, 2026

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

Published on: December 27, 2024

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

Main Results:

Evidence highlights the role of skin barrier dysfunction in AD.
Current management often focuses on reactive inflammation suppression.
Allergy testing presents diagnostic limitations.

Conclusions:

Clinicians should consider proactive management for young dogs with AD.
Improving skin barrier function may prevent future allergic sensitization.
A paradigm shift from reactive to proactive AD management is warranted.